Key result
Total artificial hearts continue to serve as a beneficial bridge to transplantation for patients with biventricular failure who fail to improve with medical therapy or left ventricular assist devices.
Population
Patients with advanced biventricular heart failure
Design
Review
Authors
Loading...
Supports TAH use as bridge in refractory biventricular failure; leaves open need for randomized trials to refine selection.
Total artificial hearts remain a crucial bridge to transplantation for patients with advanced biventricular heart failure who fail medical therapy or are unsuitable for left ventricular assist devices.
Arabía et al. (2014) conducted a review in Biventricular Heart Failure. Total Artificial Heart (TAH) vs. Pharmacological agents and left ventricular assist devices was evaluated. Total artificial hearts continue to serve as a beneficial bridge to transplantation for patients with biventricular failure who fail to improve with medical therapy or left ventricular assist devices.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: